Back to Search Start Over

A double-blind study of bupropion and placebo in depression.

Authors :
Feighner JP
Meredith CH
Stern WC
Hendrickson G
Miller LL
Source :
The American journal of psychiatry [Am J Psychiatry] 1984 Apr; Vol. 141 (4), pp. 525-9.
Publication Year :
1984

Abstract

Bupropion HCl, a new nontricyclic antidepressant, produced marked improvement in 49 hospitalized patients with primary depression at doses of 300-600 mg/day. Bupropion resulted in statistically significant differences from placebo as early as day 5, and by the end of the 4-week study 79% (N = 27) of the bupropion patients and 13% (N = 2) of the placebo patients showed much to very much improvement. Bupropion and placebo had similar side effect profiles. Tremor and sweating were reported more often with bupropion and headache, nausea, and tiredness with placebo.

Details

Language :
English
ISSN :
0002-953X
Volume :
141
Issue :
4
Database :
MEDLINE
Journal :
The American journal of psychiatry
Publication Type :
Academic Journal
Accession number :
6422779
Full Text :
https://doi.org/10.1176/ajp.141.4.525